Peripheral Arterial Disease — Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease
Citation(s)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.